PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
27710897-3	2016	BZ-26 had shown stronger interaction with PPARgamma and had higher transcriptional inhibitory activity of PPARgamma with lower dosage compared with GW9662.	bz-26	0-5	peroxisome proliferator activated receptor gamma	Mus musculus	42-51
27710897-3	2016	BZ-26 had shown stronger interaction with PPARgamma and had higher transcriptional inhibitory activity of PPARgamma with lower dosage compared with GW9662.	bz-26	0-5	peroxisome proliferator activated receptor gamma	Mus musculus	106-115
27710897-6	2016	And the results showed that BZ-26 administration attenuated plasma tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) secretion, which are vital cytokines in acute inflammation.	bz-26	28-33	tumor necrosis factor	Mus musculus	67-94
27710897-6	2016	And the results showed that BZ-26 administration attenuated plasma tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) secretion, which are vital cytokines in acute inflammation.	bz-26	28-33	tumor necrosis factor	Mus musculus	96-105
27710897-6	2016	And the results showed that BZ-26 administration attenuated plasma tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) secretion, which are vital cytokines in acute inflammation.	bz-26	28-33	interleukin 6	Mus musculus	111-124
27710897-6	2016	And the results showed that BZ-26 administration attenuated plasma tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) secretion, which are vital cytokines in acute inflammation.	bz-26	28-33	interleukin 6	Mus musculus	126-130